Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-18 4:15 pm Sale | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Ltd | 2,000,000 2.000% | -6,092,000 (-75.28%) | View |
| 2024-10-11 06:01 am Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | ASTRAZENECA PLC AZN | 9,504,465 9.900% | 9,504,465 (New Position) | View |
| 2024-10-07 7:36 pm Sale | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Ltd | 8,092,000 8.300% | -6,408,000 (-44.19%) | View |
| 2024-09-19 4:59 pm Sale | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Corvus Capital Ltd. | 30,292,731 31.560% | -15,301,068 (-33.56%) | View |
| 2024-08-13 4:29 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Ltd | 14,500,000 14.800% | 7,979,689 (+122.38%) | View |
| 2024-02-12 12:51 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Polar Asset Management Partners Inc. | 950,000 1.300% | 950,000 (New Position) | View |
| 2024-02-08 1:15 pm Unchanged | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Saba Capital Management L.P. | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-02 4:28 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Hudson Bay Capital Management LP | 73,078 0.100% | 73,078 (New Position) | View |
| 2023-10-02 4:30 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Ltd | 6,520,311 8.800% | 6,520,311 (New Position) | View |
| 2023-09-29 4:30 pm Purchase | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Corvus Capital Ltd. | 45,593,799 62.960% | 45,593,799 (New Position) | View |
| 2023-09-29 4:30 pm Purchase | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Murphy Canyon Acquisition Sponsor LLC | 4,724,250 6.500% | 4,724,250 (New Position) | View |
| 2023-09-29 4:30 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | St George Street Capital | 4,749,816 6.600% | 4,749,816 (New Position) | View |
| 2023-02-16 5:28 pm Purchase | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Shaolin Capital Management LLC | 609,750 20.730% | 609,750 (New Position) | View |
| 2023-02-14 12:08 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | MMCAP International Inc. SPC | 350,000 2.500% | 350,000 (New Position) | View |
| 2023-02-10 2:54 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Hudson Bay Capital Management LP | 934,112 6.680% | 934,112 (New Position) | View |
| 2023-02-10 1:46 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Polar Asset Management Partners Inc. | 700,000 5.010% | 700,000 (New Position) | View |
| 2023-02-07 7:31 pm Unchanged | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Space Summit Capital LLC | 0 0.000% | 0 (Unchanged) | View |
| 2023-01-30 5:00 pm Unchanged | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Murphy Canyon Acquisition Sponsor LLC | 4,060,250 23.490% | 0 (Unchanged) | View |
| 2022-02-14 4:30 pm Purchase | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Murphy Canyon Acquisition Sponsor LLC | 4,060,250 23.490% | 4,060,250 (New Position) | View |
| 2022-02-11 4:00 pm Purchase | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Saba Capital Management L.P. | 765,000 5.500% | 765,000 (New Position) | View |